210 related articles for article (PubMed ID: 18184662)
1. Prognostic value of plasma soluble CD40 ligand in patients with chronic non-valvular atrial fibrillation.
Duygu H; Barisik V; Kurt H; Turk U; Ercan E; Kose S
Europace; 2008 Feb; 10(2):210-4. PubMed ID: 18184662
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
[TBL] [Abstract][Full Text] [Related]
3. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
4. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.
Habara S; Dote K; Kato M; Sasaki S; Goto K; Takemoto H; Hasegawa D; Matsuda O
Eur Heart J; 2007 Sep; 28(18):2217-22. PubMed ID: 17716991
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD40 ligand and atrial fibrillation: relationship to platelet activation, and endothelial damage/dysfunction.
Blann AD; Choudhury A; Freestone B; Patel J; Lip GY
Int J Cardiol; 2008 Jun; 127(1):135-7. PubMed ID: 17555832
[TBL] [Abstract][Full Text] [Related]
6. Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF).
Pinto A; Tuttolomondo A; Casuccio A; Di Raimondo D; Di Sciacca R; Arnao V; Licata G
Clin Sci (Lond); 2009 May; 116(10):781-9. PubMed ID: 18980576
[TBL] [Abstract][Full Text] [Related]
7. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of CHADS2 score to predict C-reactive protein, left atrial blood stasis, and prognosis in patients with nonrheumatic atrial fibrillation.
Maehama T; Okura H; Imai K; Yamada R; Obase K; Saito K; Hayashida A; Neishi Y; Kawamoto T; Yoshida K
Am J Cardiol; 2010 Aug; 106(4):535-8. PubMed ID: 20691312
[TBL] [Abstract][Full Text] [Related]
9. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation.
Boyd AC; McKay T; Nasibi S; Richards DA; Thomas L
Eur Heart J Cardiovasc Imaging; 2013 Mar; 14(3):269-75. PubMed ID: 22833549
[TBL] [Abstract][Full Text] [Related]
10. Comparison of diverse platelet activation markers as indicators for left atrial thrombus in atrial fibrillation.
Tarnowski D; Poitz DM; Plichta L; Heidrich FM; Wiedemann S; Ruf T; Mierke J; Löhn T; Jellinghaus S; Strasser RH; Ibrahim K; Pfluecke C
Platelets; 2018 Jan; 29(1):41-47. PubMed ID: 28287031
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD40L, platelet surface CD40L and total platelet CD40L in congestive heart failure: relationship to platelet volume, mass and granularity.
Chung I; Choudhury A; Patel J; Lip GY
J Intern Med; 2008 Mar; 263(3):313-21. PubMed ID: 18086125
[TBL] [Abstract][Full Text] [Related]
12. Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):685-9. PubMed ID: 9307554
[TBL] [Abstract][Full Text] [Related]
13. Soluble CD40 ligand:interleukin-10 ratio predicts in-hospital adverse events in patients with ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC
Thromb Res; 2007; 121(3):293-9. PubMed ID: 17521712
[TBL] [Abstract][Full Text] [Related]
14. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes.
Yan JC; Zhu J; Gao L; Wu ZG; Kong XT; Zong RQ; Zhan LZ
Clin Chim Acta; 2004 May; 343(1-2):155-9. PubMed ID: 15115688
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease.
Türker S; Güneri S; Akdeniz B; Ozcan MA; Baris N; Badak O; Kirimli O; Yüksel F
Am J Cardiol; 2006 Jan; 97(2):198-202. PubMed ID: 16442363
[TBL] [Abstract][Full Text] [Related]
16. Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation.
Saeed M; Rahman A; Afzal A; Agoston I; Jammula P; Birnbaum Y; Ware DL; Uretsky BF; Schwarz ER; Rosanio S
Int J Cardiol; 2006 Nov; 113(3):401-5. PubMed ID: 16822564
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD40 ligand is predictive of combined cardiovascular morbidity and mortality in patients on haemodialysis at a relatively short-term follow-up.
Desideri G; Panichi V; Paoletti S; Grassi D; Bigazzi R; Beati S; Bernabini G; Rosati A; Ferri C; Taddei S; Ghiadoni L;
Nephrol Dial Transplant; 2011 Sep; 26(9):2983-8. PubMed ID: 21303961
[TBL] [Abstract][Full Text] [Related]
18. Platelet expression of CD40/CD40 ligand and its relation to inflammatory markers and adhesion molecules in patients with atrial fibrillation.
Hammwöhner M; Ittenson A; Dierkes J; Bukowska A; Klein HU; Lendeckel U; Goette A
Exp Biol Med (Maywood); 2007 Apr; 232(4):581-9. PubMed ID: 17392495
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
20. Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.
Desideri G; Cipollone F; Necozione S; Marini C; Lechiara MC; Taglieri G; Zuliani G; Fellin R; Mezzetti A; di Orio F; Ferri C
Neurobiol Aging; 2008 Mar; 29(3):348-56. PubMed ID: 17123665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
